Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
84 participants
INTERVENTIONAL
2019-03-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Assisted Hatching on Vitrified Embryo Transfer Clinical Outcome
NCT02124291
The Effect of Laser Assisted Hatching in Thawing Cycles: a Prospective Randomized Controlled Study
NCT00593775
The Impact of Early Embryos Incubation on Pregnancy Rate in IVF
NCT01287273
Study of Assisted Hatching of Cleavage Stage Embryos
NCT00120549
Synchronizing Blastocyst in Frozen Embryo Transfer
NCT03128970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Assisted hatching
Five-day frozen embryos will undergo assisted hatching prior to embryo transfer
Assisted hatching
Controlled hatching of the zona pellucida in the laboratory prior to embryo transfer
Control
Five-day frozen embryos will not undergo any additional procedures prior to embryo transfer
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assisted hatching
Controlled hatching of the zona pellucida in the laboratory prior to embryo transfer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 39 years old
* First to third treatment cycle
* Patient has previously had a maximum of four embryos transferred.
Exclusion Criteria
* Congenital or acquired uterine malformations
* Hydrosalpinx
* Chronic autoimmune diseases
* Embryo intended to be undergo preimplantation genetic diagnosis
18 Years
39 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wolfson Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadas Ganer Herman
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hadas Ganer Herman, MD
Role: PRINCIPAL_INVESTIGATOR
Edith Wolfson Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edith Wolfson Medical Center
Holon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hadas Ganer Herman, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0020-19-WOMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.